Oxycodone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for oxycodone and what is the scope of patent protection?

Oxycodone is the generic ingredient in six branded drugs marketed by Collegium Pharm Inc, Ani Pharms Inc, Avanthi Inc, Genus Lifesciences, Lannett Co Inc, Mayne Pharma Inc, Novel Labs Inc, Abhai Llc, Akorn, Alkem Labs Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Eywa, Hikma, Pharm Assoc, Rhodes Pharms, Specgx Llc, Vistapharm, Wockhardt Bio Ag, Purdue Pharma Lp, Roxane, Zyla, Actavis Elizabeth, Alvogen, Amneal Pharms, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Sun Pharm Inds Inc, Vintage Pharms, and Ohemo Life, and is included in fifty-two NDAs. There are fifty patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxycodone has twenty-four patent family members in thirteen countries.

There are nineteen drug master file entries for oxycodone. One supplier is listed for this compound. There are four tentative approvals for this compound.

Summary for oxycodone

International Patents:	24
US Patents:	50
Tradenames:	6
Applicants:	31
NDAs:	52
Drug Master File Entries:	19
Suppliers / Packagers:	1
Bulk Api Vendors:	19
Clinical Trials:	478
Patent Applications:	4,730
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for oxycodone
Drug Sales Revenues:	Drug sales revenues for oxycodone
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for oxycodone
What excipients (inactive ingredients) are in oxycodone?	oxycodone excipients list
DailyMed Link:	oxycodone at DailyMed

See drug prices for oxycodone

See drug sales revenues for oxycodone

Recent Clinical Trials for oxycodone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Oklahoma	Early Phase 1
Washington University School of Medicine	N/A
NYU Langone Health	Phase 4

See all oxycodone clinical trials

Generic filers with tentative approvals for OXYCODONE

Applicant	Application No.	Strength	Dosage Form
Start Trial	Start Trial	80MG	TABLET, EXTENDED RELEASE; ORAL
Start Trial	Start Trial	80MG	TABLET, EXTENDED RELEASE; ORAL
Start Trial	Start Trial	10MG	TABLET, EXTENDED RELEASE; ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for oxycodone

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

Medical Subject Heading (MeSH) Categories for oxycodone

Analgesics, Opioid
Narcotics

Paragraph IV (Patent) Challenges for OXYCODONE

Tradename	Dosage	Ingredient	NDA	Submissiondate
XTAMPZA ER	CAPSULE, EXTENDED RELEASE;ORAL	oxycodone	208090	2017-11-15

US Patents and Regulatory Information for oxycodone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Specgx Llc	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	SOLUTION;ORAL	210758-002	Apr 30, 2018	AA	RX	No	No	Start Trial	Start Trial				Start Trial
Collegium Pharm Inc	XTAMPZA ER	oxycodone	CAPSULE, EXTENDED RELEASE;ORAL	208090-005	Apr 26, 2016		RX	Yes	Yes	Start Trial	Start Trial	Y			Start Trial
Purdue Pharma Lp	OXYCONTIN	oxycodone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022272-005	Apr 5, 2010		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Nuvo Pharm	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	TABLET;ORAL	207119-004	Apr 12, 2016	AB	RX	No	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for oxycodone

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Japan	4694207	Start Trial
Japan	2013216707	Start Trial
Canada	2916869	Start Trial
Canada	2569958	Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for oxycodone

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1685839	92292	Luxembourg	Start Trial	PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.